Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Antitumor Combinations Containing Anti Ceacam5 Antibody Drug Conjugates, Anti Vegfr 2 Antibodies And Anti Pd1/Pd L1 Antibodies
Abstract: The disclosure relates to a combination of (i) an antibody-drug conjugate (ADC) comprising an anti-CEACAM5 antibody, (ii) a VEGFR-2 inhibitor, and (iii) an anti-PD-1 antibody or anti-PD-L1 antibody, for use in the treatment of a cancer.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
03 October 2025
Publication Number
52/2025
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
SANOFI
46 avenue de la Grande Armée
75017 PARIS
ELI LILLY AND COMPANY
Lilly Corporate Center
INDIANAPOLIS, Indiana 46285
Inventors
1. CHADJAA, Mustapha
c/o SANOFI, Patent Department
46 avenue de la Grande Armée
75017 PARIS
2. DENNIS, Philip
c/o SANOFI, Patent Department
450 Water Street
CAMBRIDGE, Massachusetts 02141
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202517095213-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [03-10-2025(online)].pdf | 2025-10-03 |
| 2 | 202517095213-STATEMENT OF UNDERTAKING (FORM 3) [03-10-2025(online)].pdf | 2025-10-03 |
| 4 | 202517095213-Sequence Listing in PDF [03-10-2025(online)].pdf | 2025-10-03 |
| 5 | 202517095213-REQUEST FOR EXAMINATION (FORM-18) [03-10-2025(online)].pdf | 2025-10-03 |
| 6 | 202517095213-FORM 18 [03-10-2025(online)].pdf | 2025-10-03 |
| 7 | 202517095213-FORM 1 [03-10-2025(online)].pdf | 2025-10-03 |
| 8 | 202517095213-DRAWINGS [03-10-2025(online)].pdf | 2025-10-03 |
| 9 | 202517095213-DECLARATION OF INVENTORSHIP (FORM 5) [03-10-2025(online)].pdf | 2025-10-03 |
| 10 | 202517095213-COMPLETE SPECIFICATION [03-10-2025(online)].pdf | 2025-10-03 |
| 11 | 202517095213-FORM-26 [09-12-2025(online)].pdf | 2025-12-09 |